LENSAR LNSR 深 沪
等待开盘 09-08 09:30:00 美东时间
12.17
0.000
0.00%
华盛通- 最 高12.25
- 今 开12.25
- 成交量 2.30万股
- 最 低 12.04
- 昨 收 12.17
- 总市值 1.45亿
- 52周最高 17.31
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.8001
- 委 比 53.39%
- 总股本 1193.48万
- 历史最高 17.31
- 量 比 0.23
- 振 幅 1.73%
- 历史最低 1.80
- 每 手 1
- 风险率 3.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LENSAR Q2 EPS $(0.15) Compared With $(0.79) YoY, Sales $13.935M Miss $16.550M Estimate
LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.02) by 650 percent. This is a 67.39 percent increase over losses of $(0.46) per share from the same
08-07 19:28
107 亿！巨头溢价 59%收购昔日对手
（来源：CHC医疗传媒） 2025 年 8 月 5 日，全球眼科医疗巨头爱尔康（Alcon）宣布以 15 亿美元（约合107亿元人民币）收购纳斯达克上市公司...
08-07 14:30
LENSAR Stockholders Approve Merger with Alcon Research
LENSAR ( ($LNSR) ) has issued an update. On July 2, 2025, LENSAR, Inc. held a v...
07-03 04:17
快讯 | LENSAR根据纳斯达克上市规则5635(C)(4)报告诱导性授予
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
06-03 04:01
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR, Inc. announced that a majority of its independent board members granted 3,090 restricted stock units (RSUs) to 10 newly-hired non-executive employees as an inducement for joining the Company. The RSUs vest over four years, contingent on continued employment. LENSAR, a medical device company, specializes in developing advanced systems like the ALLY Robotic Cataract Laser System, which integrates AI for improved surgical outcomes and effici...
06-02 20:01
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
05-30 01:28
FTC Extends Waiting Period for LENSAR Merger
LENSAR ( ($LNSR) ) just unveiled an update. On March 23, 2025, LENSAR, Inc. ent...
05-23 05:12
LENSAR Announces Merger with Alcon Research
New activity is brewing for LENSAR ( ($LNSR) ). The company has submitted a For...
05-20 05:16
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - DNB, BRDG, LNSR, SSBK
NEW YORK, May 16, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the ...
05-17 06:30
LENSAR Q1 EPS $(2.32) Misses $(0.21) Estimate, Sales $14.16M Beat $13.40M Estimate
LENSAR (NASDAQ:LNSR) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.21) by 1004.76 percent. This is a 1121.05 percent decrease over losses of $(0.19) per share from the
05-08 19:27
